Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2
slide-3

Gliclabetic-M80 Tablet

Prescription Icon
Prescription Required

Marketer

Kepran Healthcare

Salt Composition

Gliclazide (80mg) + Metformin (500mg)

Overview Gliclabetic-M80 Tablet

Diabeticin-80, a dual-action antidiabetic medication, manages type 2 diabetes in adults. This combination therapy regulates blood glucose. Administer Diabeticin-80 with meals, consistently at the same time daily for optimal efficacy. Dosage is determined and adjusted by your physician based on your blood sugar response. Continuous use is crucial; discontinuation without medical guidance can elevate blood sugar, increasing the risk of complications like nephropathy, retinopathy, neuropathy, and limb loss. Remember, Diabeticin-80 complements a comprehensive diabetes management plan encompassing diet, exercise, and weight control as directed by your doctor. Lifestyle choices significantly impact diabetes control. Common side effects include hypoglycemia (low blood sugar), characterized by sweating, dizziness, headache, and tremors; constipation; and vomiting. Always carry a quick-acting glucose source (e.g., candy, juice) to counter hypoglycemia. Alcohol intake should be minimized due to its potential to exacerbate hypoglycemia. Other possible side effects include altered taste, nausea, diarrhea, abdominal pain, headache, and upper respiratory infections. Weight gain may occur. Diabeticin-80 is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Disclose any history of heart disease to your physician before commencing treatment. Consult your doctor before use if pregnant or breastfeeding. Regular blood glucose monitoring and periodic blood tests (complete blood count and liver function tests) are recommended.

Uses of Gliclabetic-M80 Tablet

Adult-onset diabetes

Major Benefits of Gliclabetic-M80 Tablet:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Gliclabetic-M80 Tablets should be administered with a meal.

Common Side effects of Gliclabetic-M80 Tablet:

  • Hypoglycemia (low blood glucose level)
  • Headache
  • Dizziness
  • Diarrhea
  • Upper respiratory tract infection
  • Nausea
  • Flatulence
  • Constipation

How to use Gliclabetic-M80 Tablet:

Consume this medication precisely as prescribed by your physician, adhering to the specified dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Gliclabetic-M80 Tablets should be administered with meals.

How Gliclabetic-M80 Tablet works:

Gliclazide and metformin are combined in Gliclabetic-M80 tablets to manage diabetes.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol alongside Gliclabetic-M80 tablets is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Gliclabetic-M80 tablets during pregnancy is contraindicated due to established risks to the fetus. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Physician consultation is essential.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Gliclabetic-M80 tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Gliclabetic-M80 Tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates the use of Gliclabetic-M80 Tablets. Physician consultation is recommended. Regular kidney function monitoring is advised during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Gliclabetic-M80 Tablets cautiously, potentially requiring dosage modification. Consult a physician. A low initial dose is typically recommended for those with mild to moderate liver disease; however, its use is contraindicated in patients with severe hepatic dysfunction.

What if you forget to take Gliclabetic-M80 Tablet :

Should you forget a Gliclabetic-M80 Tablet dose, take it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing pattern. Avoid taking a double dose.

Facts to Know About Gliclabetic-M80 Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Gliclabetic-M80 Tablet

Gliclabetic-M80 tablets combine gliclazide and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Gliclazide stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 diabetes.
Gliclabetic-M80 Tablet may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infection. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Gliclabetic-M80 Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Therefore, regular blood sugar monitoring is crucial. Carry glucose tablets, honey, or fruit juice for emergencies.
Gliclabetic-M80 Tablets can cause lactic acidosis, a serious medical emergency (also known as MALA, or Metformin-associated lactic acidosis) resulting from excessive blood lactic acid. This rare side effect is preventable by avoiding use in patients with kidney disease, the elderly, or those who consume large amounts of alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If these occur, discontinue Gliclabetic-M80 and seek immediate medical attention.
Prolonged Gliclabetic-M80 Tablet use can lead to vitamin B12 deficiency by interfering with its stomach absorption. This deficiency, if left untreated, may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness), urinary issues, cognitive changes, and balance problems (ataxia). To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Gliclabetic-M80 Tablets are contraindicated in patients with allergies to any ingredient or excipient. They should also not be used by individuals with moderate to severe kidney disease or metabolic acidosis, including diabetic ketoacidosis.
Combining Gliclabetic-M80 tablets and alcohol is unsafe. Alcohol can worsen hypoglycemia and raise the risk of lactic acidosis.
Gliclabetic-M80 tablets combine gliclazide and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Gliclazide stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. This medication is unsuitable for type 1 diabetes.
Gliclabetic-M80 Tablets may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Gliclabetic-M80 Tablets can cause hypoglycemia (low blood sugar). Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, and anxiety or shakiness. Hypoglycemia risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Regular blood sugar monitoring is crucial. Carry glucose tablets, honey, or fruit juice for emergencies.
Gliclabetic-M80 Tablets can cause lactic acidosis, a serious medical emergency (also known as MALA, or Metformin-associated lactic acidosis) resulting from excessive blood lactic acid. This rare side effect is preventable by avoiding use in patients with kidney disease, the elderly, or those who consume excessive alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If these occur, discontinue Gliclabetic-M80 and seek immediate medical attention.
Prolonged Gliclabetic-M80 Tablet use can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency, if left untreated, may result in anemia, nerve damage (manifested as tingling, numbness in extremities, weakness), urinary issues, cognitive changes, and balance problems (ataxia). To mitigate this risk, supplemental vitamin B12 intake is recommended annually, according to some researchers.
Gliclabetic-M80 Tablets are contraindicated in patients with known allergies to any ingredient or excipient. They should also be avoided in those with moderate to severe kidney disease or metabolic acidosis, including diabetic ketoacidosis.
Combining Gliclabetic-M80 tablets and alcohol is unsafe. Alcohol can worsen low blood sugar and raise the risk of lactic acidosis.
Gliclabetic-M80 Tablet
74
MRP 90
17% off